Impact of COVID-19 on the management of patients with thoracic cancers in a tertiary referral center

被引:6
作者
Basse, Clemence [1 ]
Daniel, Catherine [1 ]
Livartowski, Alain [1 ]
Beaucaire-Danel, Sophie [1 ]
Girard, Nicolas [1 ,2 ]
机构
[1] Inst Curie, Paris, France
[2] Univ Paris Saclay, Univ Versailles St Quentin, Unite Format & Rech Simone Veil Sante, Montigny Le Bretonneux, France
关键词
Lung cancer; COVID-19; Guidelines; Immunotherapy;
D O I
10.1016/j.lungcan.2021.05.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 has spread worldwide in 2020 leading the World Health Organization to declare a pandemic. Patients with thoracic cancers have been reported at higher risk to develop severe disease, and die from COVID-19. In this setting, clinical practice recommendations for the management of patients were published. We report here how these guidelines were implemented in a routine practice setting. Methods: We retrospectively collected the characteristics, treatment regimen and modification, as well as COVID19 status and death for all patients with thoracic malignancies scheduled for an appointment at Institute Curie from March 23rd to April 17th 2020. Results: A total of 339 patients were included. Treatment strategy was modified for a total of 110 (32 %) patients because of COVID-19; these modifications were in accordance with guidelines for 92 % of patients. The majority of dose modifications were related to immune checkpoint inhibitors, for which switch to flat dosing every 4-6 weeks was made. A total of 5 (1.5 %) patients were diagnosed with COVID-19 disease, 1 of whom died from disease complication. Conclusion: Our study provides a unique insight in the decision making for patients with thoracic malignancies in the setting of COVID-19 outbreak, showing how guidelines were implemented in the clinic, and what may be optimized in the clinical practice of thoracic oncology in the future.
引用
收藏
页码:79 / 84
页数:6
相关论文
共 9 条
[1]  
[Anonymous], Dashboard: Nikshay Reports
[2]   How we treat patients with lung cancer during the SARS-CoV-2 pandemic:primum non nocere [J].
Banna, Giuseppe ;
Curioni-Fontecedro, Alessandra ;
Friedlaender, Alex ;
Addeo, Alfredo .
ESMO OPEN, 2019, 4
[3]   Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus [J].
Curigliano, G. ;
Banerjee, S. ;
Cervantes, A. ;
Garassino, M. C. ;
Garrido, P. ;
Girard, N. ;
Haanen, J. ;
Jordan, K. ;
Lordick, F. ;
Machiels, J. P. ;
Michielin, O. ;
Peters, S. ;
Tabernero, J. ;
Douillard, J. Y. ;
Pentheroudakis, G. .
ANNALS OF ONCOLOGY, 2020, 31 (10) :1320-1335
[4]   Proposals for managing patients with thoracic malignancies during COVID-19 pandemic [J].
Girard, N. ;
Greillier, L. ;
Zalcman, G. ;
Cadranel, J. ;
Moro-Sibilot, D. ;
Mazieres, J. ;
Audigier-Valette, C. ;
Bennouna, J. ;
Besse, B. ;
Cortot, A. ;
Couraud, S. ;
Duruisseaux, M. ;
Giroux-Leprieur, E. ;
Toffart, A-C ;
Westeel, V ;
Wislez, M. .
RESPIRATORY MEDICINE AND RESEARCH, 2020, 78
[5]   Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [J].
Huang, Chaolin ;
Wang, Yeming ;
Li, Xingwang ;
Ren, Lili ;
Zhao, Jianping ;
Hu, Yi ;
Zhang, Li ;
Fan, Guohui ;
Xu, Jiuyang ;
Gu, Xiaoying ;
Cheng, Zhenshun ;
Yu, Ting ;
Xia, Jiaan ;
Wei, Yuan ;
Wu, Wenjuan ;
Xie, Xuelei ;
Yin, Wen ;
Li, Hui ;
Liu, Min ;
Xiao, Yan ;
Gao, Hong ;
Guo, Li ;
Xie, Jungang ;
Wang, Guangfa ;
Jiang, Rongmeng ;
Gao, Zhancheng ;
Jin, Qi ;
Wang, Jianwei ;
Cao, Bin .
LANCET, 2020, 395 (10223) :497-506
[6]   Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding [J].
Lu, Roujian ;
Zhao, Xiang ;
Li, Juan ;
Niu, Peihua ;
Yang, Bo ;
Wu, Honglong ;
Wang, Wenling ;
Song, Hao ;
Huang, Baoying ;
Zhu, Na ;
Bi, Yuhai ;
Ma, Xuejun ;
Zhan, Faxian ;
Wang, Liang ;
Hu, Tao ;
Zhou, Hong ;
Hu, Zhenhong ;
Zhou, Weimin ;
Zhao, Li ;
Chen, Jing ;
Meng, Yao ;
Wang, Ji ;
Lin, Yang ;
Yuan, Jianying ;
Xie, Zhihao ;
Ma, Jinmin ;
Liu, William J. ;
Wang, Dayan ;
Xu, Wenbo ;
Holmes, Edward C. ;
Gao, George F. ;
Wu, Guizhen ;
Chen, Weijun ;
Shi, Weifeng ;
Tan, Wenjie .
LANCET, 2020, 395 (10224) :565-574
[7]   ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer [J].
Passaro, Antonio ;
Addeo, Alfredo ;
Von Garnier, Christophe ;
Blackhall, Fiona ;
Planchard, David ;
Felip, Enriqueta ;
Dziadziuszko, Rafal ;
de Marinis, Filippo ;
Reck, Martin ;
Bouchaab, Hasna ;
Peters, Solange .
ESMO OPEN, 2020, 5 :1-10
[8]  
Sante Publique France, 2020, POINT EP 23 SEPT
[9]   Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention [J].
Wu, Zunyou ;
McGoogan, Jennifer M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (13) :1239-1242